U.S. markets closed
  • S&P 500

    3,678.43
    +92.81 (+2.59%)
     
  • Dow 30

    29,490.89
    +765.38 (+2.66%)
     
  • Nasdaq

    10,815.43
    +239.82 (+2.27%)
     
  • Russell 2000

    1,708.87
    +44.15 (+2.65%)
     
  • Crude Oil

    83.34
    +3.85 (+4.84%)
     
  • Gold

    1,708.60
    +36.60 (+2.19%)
     
  • Silver

    20.76
    +1.72 (+9.04%)
     
  • EUR/USD

    0.9826
    +0.0025 (+0.26%)
     
  • 10-Yr Bond

    3.6510
    -0.1530 (-4.02%)
     
  • GBP/USD

    1.1320
    +0.0154 (+1.38%)
     
  • USD/JPY

    144.5500
    -0.1790 (-0.12%)
     
  • BTC-USD

    19,568.85
    +405.09 (+2.11%)
     
  • CMC Crypto 200

    444.05
    +8.70 (+2.00%)
     
  • FTSE 100

    6,908.76
    +14.95 (+0.22%)
     
  • Nikkei 225

    26,215.79
    +278.58 (+1.07%)
     

Is Trending Stock Cenovus Energy Inc (CVE) a Buy Now?

·5 min read

Cenovus Energy (CVE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Over the past month, shares of this oil company have returned -12.5%, compared to the Zacks S&P 500 composite's +7.3% change. During this period, the Zacks Oil and Gas - Integrated - Canadian industry, which Cenovus falls in, has lost 7.7%. The key question now is: What could be the stock's future direction?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Earnings Estimate Revisions

Rather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

For the current quarter, Cenovus is expected to post earnings of $0.80 per share, indicating a change of +788.9% from the year-ago quarter. The Zacks Consensus Estimate has changed +7.7% over the last 30 days.

For the current fiscal year, the consensus earnings estimate of $3.02 points to a change of +272.8% from the prior year. Over the last 30 days, this estimate has changed +6.5%.

For the next fiscal year, the consensus earnings estimate of $2.89 indicates a change of -4.1% from what Cenovus is expected to report a year ago. Over the past month, the estimate has changed +4.5%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Cenovus is rated Zacks Rank #1 (Strong Buy).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

12-month consensus EPS estimate for CVE _12MonthEPSChartUrl
12-month consensus EPS estimate for CVE _12MonthEPSChartUrl

Revenue Growth Forecast

Even though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

In the case of Cenovus, the consensus sales estimate of $12.56 billion for the current quarter points to a year-over-year change of +45.9%. The $49.91 billion and $45.8 billion estimates for the current and next fiscal years indicate changes of +32.4% and -8.2%, respectively.

Last Reported Results and Surprise History

Cenovus reported revenues of $14.18 billion in the last reported quarter, representing a year-over-year change of +88.5%. EPS of $0.62 for the same period compares with $0.08 a year ago.

Compared to the Zacks Consensus Estimate of $10.69 billion, the reported revenues represent a surprise of +32.62%. The EPS surprise was -3.12%.

Over the last four quarters, the company surpassed EPS estimates just once. The company topped consensus revenue estimates two times over this period.

Valuation

Without considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an An is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Cenovus is graded B on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Conclusion

The facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Cenovus. However, its Zacks Rank #1 does suggest that it may outperform the broader market in the near term.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Cenovus Energy Inc (CVE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.